Drug industry to announce revised code on marketing
Gifts that drug makers have long showered on doctors will be banned from pharmaceutical marketing campaigns under new voluntary guidelines titled the "Code on Interactions with Health Care Professionals." The guidelines will ask the chief executives of large drug makers to certify in writing that "they have policies and procedures in place to foster compliance with the code." The code, however, provides no definite limits on the millions of dollars spent on speaking and consulting arrangements that drug makers have forged with doctors. The code was written by the Pharmaceutical Research and Manufacturers of America.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Transforming Cancer Care
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Proton Beam Therapy Poised for Growth in US
- Sharp HealthCare Leaves Pioneer ACO Program